Hematology NewsNovel AKT inhibitor active against MM cellsSeptember 12, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesMRD data added to venetoclax labelSeptember 12, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsTP53 mutation plus complex karyotype equals poor prognosisSeptember 10, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology TimesNew guidelines on antimicrobial prophylaxisSeptember 9, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesTransplantation
Hematology TimesFirst CAR T-cell therapy approved in CanadaSeptember 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsPharmacyALLAggressive LymphomasFollicular Lymphoma
Hematology TimesRegimens produce similar results in FLSeptember 7, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesIbrutinib maintains efficacy over timeSeptember 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsRESONATE-2 update: First-line ibrutinib has sustained efficacy in older CLL patientsSeptember 6, 2018CLLAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsRituximab/lenalidomide similar to rituximab/chemotherapy for follicular lymphomaSeptember 6, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsEscalating methotrexate may improve survival in T-cell ALLSeptember 5, 2018ALLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology TimesTYK2 inhibitors could treat ALCL, team saysSeptember 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsDaratumumab approved in Europe for new myeloma indicationSeptember 4, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsAdverse events outweigh promise of SGN-CD70A against NHLAugust 30, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesPredicting early outcomes in DLBCLAugust 30, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsFracture risk linked to mortality in women with myelomaAugust 29, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
